On the creation of a pharmaceutical safety system in the Russian Federation
Keywords:
history of health care, pharmaceutical safety, pharmaceutical industry, medicines, drug provisionAbstract
This article analyzes the formation and development of a pharmaceutical safety system in the Russian Federation, which was designed to protect the population and health organizations from threats arising in the production, distribution and consumption of pharmaceuticals. The most difficult period was 1991–1998, which was characterized by a sharp decline in the pharmaceutical industry’s economic potential in connection with the transition to new, market-based management mechanisms and the lack of an adequate regulatory framework for pharmaceutical management. A second period began after the adoption in 1998 of the federal law On Medicines, in which for the first time the priority of state control and regulation of production, manufacturing,quality, efficiency, and safety of medicines was declared. However, opposition from the pharmaceutical industry and the inertia of state authorities in developing a regulatory legal framework detailing federal law provisions did not achieve positive results. Therefore, in 2009, the “Strategy for the development of the pharmaceutical industry of the Russian Federation for the period until 2020” was approved, marking the beginning of the modern period of improving the pharmaceutical safety system.
he new federal law On the distribution of Medicines (2010) with the necessary set of normative legal acts and the “Strategy for the provision of medicines to the population of the Russian Federation for the period until 2025” (2013) set out a sequence of tasks for solving problems concerning the country’s medicinal independence and providing the population with the necessary pharmaceutical products. In general, it is noted that the level of pharmaceutical safety has increased in Russia. The authors point out that the concept of “pharmaceutical safety” has undergone changes and currently presupposes not only a patient’s personal safety when using medicines, but also the country’s medicinal independence.
Downloads
References
Grazhdanskaya zashchita. Entsiklopediya v 4-kh tomakh.
[Civil protection. Encyclopedia in 4 volumes]. Vol. 1. Ed.
by V.A. Puchkov. Moscow: FGBU VNII GOChS (FTs),
P. 119. (In Russ.)
Moshkova L.V., Korzhavyh Eh.A., Kuznecov D.A.
Sovremennye problemy farmacevticheskoy bezopasnosti
[Modern problems of pharmaceutical safety]. Zhizn’
bez opasnostey. Zdorov’e. Profilaktika. Dolgoletie [Life
without dangers. Health. Prevention. Longevity]. 2011; 1:
–27 p. (In Russ.)
Miroshnichenko Yu.V., Goryachev A.B., Bunin S.A,
Umarov S.Z. Metodologicheskie aspekty povysheniya
effektivnosti lekarstvennoy pomoshchi v Vooruzhennykh Silakh [Methodological aspects of increasing the
effectiveness of medicinal care in the Armed Forces].
Vestnik Rossiyskoy voenno-meditsinskoy akademii
[Bulletin of the Russian military medical academy]. 2008;
: 147–153. (In Russ.)
Semenchenko V.F. Khronika farmatsii [Pharmacy
chronicle]. Moscow: Al’fa-M, 2007. 640 p. (In Russ.)
Sorokina T.S. Istoriya meditsiny [History of medicine].
Moscow: Akademiya, 2005. 560 p. (In Russ.)
Smirnov E.I. Voyna i voennaya meditsina: mysli i
vospominaniya [War and military medicine: thoughts and
memories]. Moscow: Meditsina, 1979. 526 p. (In Russ.)
Lopatin P.V. Vklad farmatsevticheskikh rabotnikov v
Velikuyu Pobedu [Pharmaceutical workers’ contribution
to the Great Victory]. Rossiyskie apteki [Russian
pharmacy]. 2005; 5: 44–46. (In Russ.)
Nadradze A.G. Khimiko-farmatsevticheskaya promyshlennost’ – meditsine [Chemical and pharmaceutical
industry – medicine]. Moscow: Znanie, 1985. 64 p.
(In Russ.)
Dorofeev V.I. Farmatsevticheskaya promyshlennost’
Rossii v usloviyakh perekhodnogo perioda [Pharmaceutical
industry in Russia during the transition period]. Moscow:
Meditsina, 1995. 144 p. (In Russ.)
Balashov A.I. Innovatsionnoe razvitie farmatsevticheskoy otrasli kak instrument obespecheniya
lekarstvennoy bezopasnosti strany [Innovative
development of the pharmaceutical industry as a tool to
ensure drug safety of the country]. Natsional’nye interesy:
prioritety i bezopasnost’ [National interests: priorities and
security]. 2011; 26: 58–63. (In Russ.)
Bunyatyan N.D. Politika bezopasnosti lekarstvennykh
sredstv v Rossii i stranakh mirovogo soobshchestva
[Drug safety policy in Russia and the world
community]. Farmatsiya [Pharmacy]. 2008; 7: 58–61.
(In Russ.)
Romanova S.A., Khabenskiy B.M. Strategicheskaya
rol’ otrasli v obespechenii natsional’noy bezopasnosti
strany [Strategic role of the industry in ensuring national
security of the country]. Remedium. 2008; 4: 6–14.
(In Russ.)
Miroshnichenko Yu.V., Goryachev A.B., Bunin S.A.,
Lemeshchenko E.Yu. Problemy farmatsevticheskoy
bezopasnosti v sisteme meditsinskogo snabzheniya voysk
(sil) [Issues of pharmaceutical security in the system of
medical provision of troops (forces)]. Vestnik Rossiyskoy
voenno-meditsinskoy akademii [Bulletin of the Russian
military medical academy]. 2013; 3: 1–5. (In Russ.)
Tel’nova E.A. O sisteme kontrolya kachestva
lekarstvennykh sredstv [About the quality control system
of medicines]. Vestnik Roszdravnadzora [Bulletin of the
Federal Service for Surveillance in Healthcare]. 2010; 4:
–16. (In Russ.)
Vlasova I. Lekarstva bez opasnosti [Drugs without
danger]. Remedium. 2003; 1–2: 90–94. (In Russ.)
Murashko M.A. Ob itogah raboty Federal’noy sluzhby po
nadzoru v sfere zdravoohraneniya v 2016 godu i planakh
na 2017 god [About results of work of Federal Service for
Surveillance in Healthcare in 2016 and plans for 2017].
Vestnik Roszdravnadzora [Bulletin of the Federal Service for
Surveillance in Healthcare]. 2017; 2: 5–16. (In Russ.)
Published
Issue
Section
License
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
